CD8A and neoplasm: M1 TAMs are initially activated by TNF-α or granulocyte–macrophage colony-stimulating factor (GM-CSF) followed by activation of Toll-like receptor signaling pathways; M1 TAMS can then recruit the cytotoxic CD8+ T and NK cells to kill the tumor cells (Mosser and Edwards, 2008).